NEW YORK (GenomeWeb) – Interpace Diagnostics said today it has closed a previously announced $13.7 million underwritten public offering.

Though the firm had aimed to raise net proceeds of $12.7 million, it said today total net proceeds were $12.2 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.